Results of EGM
Faron Pharmaceuticals Ltd ("Faron" or the "Company") Results of the Extraordinary General Meeting Company Announcement, September 22, 2023 TURKU - FINLAND / BOSTON, MA, September 22, 2023 – Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces that the extraordinary general meeting (the "EGM") of the Company took place today, September 22, 2023 in Turku, Finland. The EGM approved all proposals of the Board of Directors ("Board") as set out in the notice